IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML Cells

SIMPLE SUMMARY: Despite progress, acute myeloid leukemia (AML) remains one of the deadliest cancer diseases. The identification of novel molecular targets may allow developing innovative and alternative treatment options for AML. Using public data from genome-edited cancer cells, we identified facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Liss, Franziska, Frech, Miriam, Wang, Ying, Giel, Gavin, Fischer, Sabrina, Simon, Clara, Weber, Lisa Marie, Nist, Andrea, Stiewe, Thorsten, Neubauer, Andreas, Burchert, Andreas, Liefke, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917770/
https://www.ncbi.nlm.nih.gov/pubmed/33673123
http://dx.doi.org/10.3390/cancers13040764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917770/
https://www.ncbi.nlm.nih.gov/pubmed/33673123
http://dx.doi.org/10.3390/cancers13040764

Ejemplares similares